Aptose Biosciences Inc.
8 clinical trials · Sponsor
◉ Watch Aptose Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS (NCT04477291) | Aptose Biosciences Inc. | 2020-10-06 |
| A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas (NCT03893682) | Aptose Biosciences Inc. | 2019-04-30 |
| Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT03850574) | Aptose Biosciences Inc. | 2019-03-11 |
Track Aptose Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.